Acadia Pharmaceuticals ACAD Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Acadia Pharmaceuticals's net debt?
- Acadia Pharmaceuticals (ACAD) reported net debt of -$231.42M in Q1 2026.
- How has Acadia Pharmaceuticals's net debt changed year-over-year?
- Acadia Pharmaceuticals's net debt decreased by 43.1% year-over-year, from -$161.69M to -$231.42M.
- What is the long-term trend for Acadia Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's net debt has grown at a -14.6% compound annual growth rate (CAGR), from -$276.48M to -$125.51M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.